Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в липні 1963 (uk)
- im Juli 1963 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en xunetu de 1963 (ast)
- scientific article published on 01 July 1963 (en)
- 1963 թվականի հուլիսի 1-ին հրատարակված գիտական հոդված (hy)
|
publication date
| |
publication date
| |
language of work or name
| |
language of work or name
| |
author name string
| |
author name string
| - P E THOMPSON
- E F ELSLAGER
- D F WORTH
- B J OLSZEWSKI
|
rdfs:label
| - LABORATORY STUDIES ON 4,6DIAMINO-1-(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE PAMOATE (CI-501) AS A REPOSITORY ANTIMALARIAL DRUG (en)
- LABORATORY STUDIES ON 4,6DIAMINO-1-(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE PAMOATE (CI-501) AS A REPOSITORY ANTIMALARIAL DRUG (nl)
|
skos:prefLabel
| - LABORATORY STUDIES ON 4,6DIAMINO-1-(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE PAMOATE (CI-501) AS A REPOSITORY ANTIMALARIAL DRUG (en)
- LABORATORY STUDIES ON 4,6DIAMINO-1-(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE PAMOATE (CI-501) AS A REPOSITORY ANTIMALARIAL DRUG (nl)
|
name
| - LABORATORY STUDIES ON 4,6DIAMINO-1-(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE PAMOATE (CI-501) AS A REPOSITORY ANTIMALARIAL DRUG (en)
- LABORATORY STUDIES ON 4,6DIAMINO-1-(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE PAMOATE (CI-501) AS A REPOSITORY ANTIMALARIAL DRUG (nl)
|
title
| |
title
| - LABORATORY STUDIES ON 4,6DIAMINO-1-(P-CHLOROPHENYL)-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE PAMOATE (CI-501) AS A REPOSITORY ANTIMALARIAL DRUG (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
volume
| |
volume
| |
number of pages
| |
number of pages
| |
DOI
| |
DOI
| |
DOI
| - 10.4269/AJTMH.1963.12.481
|
is about
of | |
is cites work
of | - Biopharmaceutical Considerations in Subcutaneous and Intramuscular Drug Administration
- Cycloguanil pamoate in the treatment and suppression of malaria in the Gambia, West Africa
- PAM 1392 [2,4-diamino-6-(3,4-dichlorobenzylamino) Quinazoline] as a chemotherapeutic agent: Plasmodium berghei, P. cynomolgi, P. knowlesi, and Trypanosoma cruzi
- Recent advances in malariology
- An investigation into the suitability of amidated pectin hydrogel beads as a delivery matrix for chloroquine
- STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM VIET-NAM
- A study of resistance to cycloguanil in Plasmodium gallinaceum in chicks
- CHANGING TIDES OF CHEMOTHERAPY OF MALARIA.
- New Perspectives on the Chemotherapy of Malaria, Filariasis, and Leprosy
- Repository antimalarial drugs: N,N'-diacetyl-4,4'-diaminodiphenylsulphone and related 4-acylaminodiphenylsulphones
- Characteristics and cross-resistance patterns of chloroquine-resistant Plasmodium berghei infections in mice
- Drug resistance in Plasniodium berghei Vincke and Lips, 1948. II. Triazine resistance
- Pathologic physiology and chemotherapy of Plasmodium berghei I. Suppression of parasitemia by sulfones and sulfonamides in mice
- A rabbit-in vitro system to evaluate drug action against Plasmodium falciparum
- Prolonged Administration of Atropine or Histamine in a Silicone Rubber Implant
- Recent advances in the chemotherapy of malaria.
- Rickettsialpox
- Activities of respository preparations of cycloguanil pamoate and 4,4'-diacetyldiaminodiphenylsulfone, alone and in combination, against infections with Plasmodium cynomolgi in rhesus monkeys
- NEWS OF TROPICAL DISEASES.
- Toxicity of the repository antimalarial compound cycloguanil pamoate
|
is cites work
of | |